Results 171 to 180 of about 24,789 (234)

Combination antifibrotic and immunosuppressive therapy in progressive fibrosing ILD. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Fischer R, Abdul Rehman K.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Minocycline in early diffuse scleroderma

The Lancet, 1998
Based on its efficacy in rheumatoid arthritis and anecdotal evidence, we did an open trial of minocycline in early diffuse scleroderma. Patients satisfied criteria for the diagnosis of scleroderma and did not have additional rheumatic disease. Inclusion criteria were clinical systemic sclerosis on the extremities proximal to the elbow and knee and on ...
C H, Le, A, Morales, D E, Trentham
openaire   +2 more sources

DISSEMINATED LUPUS ERYTHEMATOSUS AND DIFFUSE SCLERODERMA

Journal of the American Medical Association, 1947
In 1942 together with Dr. Paul Klemperer we1employed the term "diffuse collagen disease" to indicate that in disseminated lupus erythematosus and in diffuse scleroderma, the basic morphologic changes were found in the connective tissues. Similar but less conspicuous changes in the connective tissues are observed also in rheumatic fever, periarteritis ...
G, BAEHR, A D, POLLACK
openaire   +2 more sources

Scleroderma, Eosinophilia, and Diffuse Fasciitis

Archives of Dermatology, 1978
• Skin induration without internal organ involvement, blood and tissue eosinophilia, and fasciitis are features of diffuse fasciitis. However, cellular infiltrates (lymphocytes, plasma cells, and eosinophils) may also be present in the dermis, fat, and muscle.
R, Fleischmajer, A B, Jacotot, S, Shore, S A, Binnick   +3 more
openaire   +3 more sources

MicroRNA Expression Abnormalities in Limited Cutaneous Scleroderma and Diffuse Cutaneous Scleroderma

Journal of Clinical Immunology, 2012
Scleroderma (systemic sclerosis, SSc) is a complex autoimmune disease caused by progressive fibrotic replacement of normal tissue architecture, a progressive and ultimately fatal process that currently has no cure. Although dysregulation of microRNAs (miRNAs) is known to be involved in a variety of pathophysiologic processes, the role of miRNAs in SSc ...
Honglin, Zhu, Yisha, Li, Shunlin, Qu, Hui, Luo, Yaou, Zhou, Yanping, Wang, Hongjun, Zhao, Yunhui, You, Xianzhong, Xiao, Xiaoxia, Zuo   +9 more
openaire   +2 more sources

NODULAR DIFFUSE SCLERODERMA

Archives of Dermatology, 1937
Scleroderma, as is well known, exists in a circumscribed form (morphea, localized scleroderma, scleroderma en bandes ) and as a diffuse type (scleroderma diffusum), in cases of which involvement of the hands (sclerodactylia) may be a prominent feature.
openaire   +1 more source

Treatment-Resistant Diffuse Calcinosis in Scleroderma

JCR: Journal of Clinical Rheumatology, 1996
A case of limited cutaneous systemic sclerosis with severe diffuse subcutaneous calcification is presented. The patient experienced multiple complications of calcinosis from this condition and was completely resistant to all treatment modalities. A detailed analysis of the calcific crystals revealed hydroxyapatite and octacalcium phosphate.
S, Vasudevan, B, Zimmermann, E V, Lally
openaire   +2 more sources

Diffuse and limited cutaneous systemic scleroderma

Current Opinion in Rheumatology, 2000
Juvenile systemic scleroderma (jSSc) is a rare disease. Based on the first large data collection on this patient group, the disease course was demonstrated to differ from that in adults. The concept of persistence of maternal cells in patients with SSc remains pathogenetically fascinating, as does the resemblance with graft-versus-host-disease. In view
openaire   +2 more sources